Science 37 Inc.

5.75
0.02 (0.35%)
At close: Mar 11, 2024, 8:00 PM

Company Description

Science 37 Holdings, Inc. provides technology-based solutions to enable agile clinical trials and decentralized approaches.

Its platform enables modern and digital approaches to clinical research by bringing together all parties, including the patient and trial investigators, nurses, coordinators, and sponsors to power workflows, centralize evidence generation, and harmonize data.

Its platform also provides specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, and connected devices for orchestrating agile clinical trials; and extensive configuration to support virtually any phase of clinical study and any indication.

In addition, the company licenses its proprietary hosted technology platform to various life science institutions.

It serves large and mid-sized pharmaceutical companies, contract research organizations, academic institutions, and biotech companies.

Science 37 Holdings, Inc. was founded in 2014 and is based in Research Triangle Park, North Carolina.

Science 37 Inc.
Science 37  Inc. logo
Country United States
IPO Date Nov 23, 2020
Industry Medical - Healthcare Information Services
Sector Healthcare
Employees 460
CEO David Coman

Contact Details

Address:
800 Park Offices Drive
Research Triangle Park, North Carolina
United States
Website https://www.science37.com

Stock Details

Ticker Symbol SNCE
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001819113
CUSIP Number 808644108
ISIN Number US8086442071
Employer ID 84-4278203
SIC Code 8731

Key Executives

Name Position
David Coman Chief Executive Officer & Director
Mike Zaranek Chief Financial Officer
Christine A. Pellizzari J.D. Chief Legal & Human Resources Officer and Secretary
Darcy Forman Chief Delivery Officer
Drew Bustos Chief Strategy & Marketing Officer
Irena Lambridis Vice President and Head of Quality Assurance & Compliance
Jonathan Cotliar M.D. Chief Medical Officer
Margie Gimbel Kooman Vice President of Marketing & Communications
Michael Shipton Chief Commercial Officer
Tyler Van Horn Vice President of Corporate Strategy & Chief of Staff

Latest SEC Filings

Date Type Title
Mar 25, 2024 15-12G Filing
Mar 14, 2024 4 Filing
Mar 14, 2024 4 Filing
Mar 14, 2024 3/A [Amend] Filing
Mar 14, 2024 SC 13D/A [Amend] Filing
Mar 13, 2024 4 Filing
Mar 13, 2024 4 Filing
Mar 13, 2024 SC 13D/A [Amend] Filing
Mar 12, 2024 4 Filing
Mar 12, 2024 4 Filing